Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase EARLY_PHASE1 3Phase 2 2Phase 4 1Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Weight Loss 1Stomach Neoplasms 1Protein Deficiency 1Pancreatic Neoplasms 1Neoplasms 1Malnutrition 1Inflammation 1Crohn Disease 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Letrozole 20Docetaxel 16Cyclophosphamide 13Zoledronic Acid 12exemestane 11Trastuzumab 11Anastrozole 11Paclitaxel 10Tamoxifen 9Capecitabine 9Fulvestrant 8Epirubicin 8pegfilgrastim 7pertuzumab 6liposomal doxorubicin 6abemaciclib 6Saline Solution 6palbociclib 5Sodium Chloride 5Dexmedetomidine 5Carboplatin 5Bupivacaine 5Bevacizumab 5ribociclib 4pegylated granulocyte colony-stimulating factor 4eribulin 4Tranexamic Acid 4Standard of Care 4Pamidronate 4Filgrastim 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Breast Neoplasms × Fish Oils × Clear all
NCT01049295 2011-11-01

Omega-3 Fatty Acids and Chemotherapy-induced Neuropathy and Inflammation in Breast Cancer

Tehran University of Medical Sciences

Phase 4 Unknown
52 enrolled
Breast

Breast Neoplasms, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡